U.S. flag

An official website of the United States government

NM_001374828.1(ARID1B):c.266G>A (p.Gly89Asp) AND ARID1B-related BAFopathy

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 10, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001533081.1

Allele description [Variation Report for NM_001374828.1(ARID1B):c.266G>A (p.Gly89Asp)]

NM_001374828.1(ARID1B):c.266G>A (p.Gly89Asp)

Genes:
ARID1B:AT-rich interaction domain 1B [Gene - OMIM - HGNC]
LOC129997523:ATAC-STARR-seq lymphoblastoid silent region 17710 [Gene]
LOC115308161:uncharacterized LOC115308161 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
6q25.3
Genomic location:
Preferred name:
NM_001374828.1(ARID1B):c.266G>A (p.Gly89Asp)
HGVS:
  • NC_000006.12:g.156777946G>A
  • NG_066624.1:g.6921G>A
  • NM_001371656.1:c.266G>A
  • NM_001374820.1:c.266G>A
  • NM_001374828.1:c.266G>AMANE SELECT
  • NM_017519.3:c.266G>A
  • NM_020732.3:c.17G>A
  • NP_001358585.1:p.Gly89Asp
  • NP_001361749.1:p.Gly89Asp
  • NP_001361757.1:p.Gly89Asp
  • NP_059989.2:p.Gly6Asp
  • NP_059989.3:p.Gly89Asp
  • NP_065783.3:p.Gly6Asp
  • NC_000006.11:g.157099080G>A
  • NM_017519.2:c.17G>A
Protein change:
G6D
Links:
dbSNP: rs1057518648
NCBI 1000 Genomes Browser:
rs1057518648
Molecular consequence:
  • NM_001371656.1:c.266G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374820.1:c.266G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374828.1:c.266G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_017519.3:c.266G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020732.3:c.17G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
ARID1B-related BAFopathy
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001748901Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 10, 2021)
de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Baylor Genetics, SCV001748901.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 14, 2023